問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Others
下載
2021-09-30 - 2022-12-31
Condition/Disease
Test Drug
Participate Sites3Sites
Terminated3Sites
2019-12-01 - 2025-12-31
Participate Sites1Sites
Recruiting1Sites
2020-08-01 - 2021-09-10
Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
CTL019
2019-08-01 - 2024-07-15
Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS)
MBG453
Participate Sites2Sites
Recruiting2Sites
2023-10-17 - 2028-12-31
2017-12-01 - 2023-12-31
Participate Sites4Sites
Terminated4Sites
2023-06-01 - 2032-02-29
Recruiting3Sites
2020-11-01 - 2035-05-31
B-cell Non-Hodgkin Lymphoma
2022-02-28 - 2025-08-18
2021-09-01 - 2023-11-28
Recruiting4Sites
全部
